Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68,771 | -292,876 | -196,200 | -146,573 | -78,096 |
| Depreciation Amortization | 499 | 4,926 | 4,542 | 4,074 | 530 |
| Accounts receivable | 6,137 | -7,698 | -12,387 | -8,106 | -5,938 |
| Accounts payable and accrued liabilities | 585 | -2,652 | -2,967 | -3,307 | -4,489 |
| Other Working Capital | -22,341 | -61,455 | -40,104 | -23,698 | -13,994 |
| Other Operating Activity | 12,791 | 121,832 | 82,531 | 59,910 | 38,352 |
| Operating Cash Flow | $-71,100 | $-237,923 | $-164,585 | $-117,700 | $-63,635 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -46,473 | -368,747 | -214,534 | -76,778 | -41,708 |
| PPE Investments | -963 | -1,544 | -1,085 | -791 | -327 |
| Sale Of Investment | 100,363 | 297,289 | 221,231 | 167,158 | 124,138 |
| Investing Cash Flow | $52,927 | $-73,002 | $5,612 | $89,589 | $82,103 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 121,703 | N/A | 59,203 | 59,203 |
| Common Stock Issued | 379 | 268,837 | 267,147 | 16,603 | 10,637 |
| Other Financing Activity | -278 | -976 | 59,203 | 0 | 0 |
| Financing Cash Flow | $101 | $389,564 | $326,350 | $75,806 | $69,840 |
| Exchange Rate Effect | -23 | -2 | 76 | -43 | N/A |
| Beginning Cash Position | 218,650 | 140,013 | 140,013 | 140,013 | 140,013 |
| End Cash Position | 200,555 | 218,650 | 307,466 | 187,665 | 228,321 |
| Net Cash Flow | $-18,095 | $78,637 | $167,453 | $47,652 | $88,308 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,100 | -237,923 | -164,585 | -117,700 | -63,635 |
| Capital Expenditure | -963 | -1,544 | -1,085 | -791 | -327 |
| Free Cash Flow | -72,063 | -239,467 | -165,670 | -118,491 | -63,962 |